Common infection in pregnancy lecture.5.58pptx.pptx

Mojiice13 54 views 64 slides Jul 30, 2024
Slide 1
Slide 1 of 64
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64

About This Presentation

Common infection in pregnancy lecture.5.58pptx.pptx


Slide Content

Common infection in pregnancy Department of Obstetrics and Gynecology, Faculty of medicine, Vajira Hospital

สามารถให้การวินิจฉัยป้องกัน และรักษาเบื้องต้นแก่โรคติดเชื้อที่พบบ่อยในหญิงตั้งครรภ์ได้ Objectives

UTIs ToRCH Toxoplasmosis Rubella Cytomegalovirus (CMV) Herpes simplex virus (HSV) Varicella zoster virus (VZV) Group B streptococcus (GBS) Outlines

Maternal and fetal immunology

Suppression of a variety of humeral and cell mediated immunological functions to accommodate the “foreign semiallogenic fetal graft” Pregnancy induced immunological changes

Passage infectious agent from the mother to fetus Placenta ( intrauterine) VZV, rubella, CMV, HIV, toxoplasmosis During labor/delivery ( intrapartum ) HSV, GBS , VZV,HIV Breast feeding (neonatal) HSV Vertical transmission

Urinary tract infections (UTIs)

Pregnancy induced urinary tract changes Asymptomatic bacteriuria Cystitis Pyelonephritis

Hypertrophy Dilatation Progesterone induced smooth muscle relaxation (before 14 weeks) Ureteral compression Rt >Lt (mid pregnancy) Increase vesicoureteral reflux Pregnancy induced urinary tract changes

Most common bacterial infection during pregnancy Organisms Normal perineal flora E. coli K. pneumoniae Enterobacter or Proteus Gram positive organism eg . GBS Urinary tract infections

Definition: persistent, actively multiplying bacteria within the urinary tract in asymptomatic women Diagnosis: clean-voided specimen containing > 10 5 organism/ml If not treated, 25% develop symptomatic infection during pregnancy Asymptomatic bacteriuria

Asymptomatic bacteriuria Single dose treatment Amoxycillin 3 g Ampicillin 2 g Cephalosporin 2 g Nitrofurantoin , 200 mg 3 – day course Amoxycillin 500 mg tid Ampicillin 250 mg qid Cephalosporin 250 mg qid Ciprofloxacin 250 mg bid Levofloxacin 250 mg OD Nitrofurantoin 50-100 mg qid , 100 mg bid

Asymptomatic bacteriuria Other Nitrofurantoin 100 mg qid 10 days Nitrofurantoin 100 mg bid 7 days Nitrofurantoin 100 mg at bedtime 10 days Treatment failures Nitrofurantoin 100 mg qid 21 days Suppression for bacterial persistence or recurrence Nitrofurantoin 100 mg hs for remainder of pregnancy

Dysuria , urgency, frequency Pyuria , bacteriuria , microscopic/gross hematuria Treatment as asymptomatic bacteriuria ( 3 day course)>>90% effective Cystitis

Most common serious medical complication of pregnancy Leading cause of septic shock during pregnancy Acute pyelonephritis

Develop frequency in 2 nd trimester > 50% unilateral and Rt side 25% bilateral Clinical finding Symptoms Fever, shaking chills Aching pain in lumbar regions Anorexia, nausea, vomiting Signs Tenderness on CVA Acute pyelonephritis

Hospitalize patient Investigation and monitoring Obtained urine and blood cultures CBC, serum Cr, electrolytes CXR if dyspnea /tachycardia Repeat CBC and chemistry studies in 48 hr Monitor V/S, urine output Plan of management

Supportive IV crystalloid for urine output ≥ 50 ml/hr Specific IV ATB Change to oral ATB when afebrile D/C when afebrile 24 hrs, consider oral ATB 7-10 days Repeat urine C/S 1-2 weeks after ATB therapy completed Plan of management

Empirical ATB Ampicillin 1 gm IV q 6 hr + gentamicin 240 mg IV OD Cefazolin 1 gm IV q 6 hr Ceftriaxone 2 gm IV OD Extended-spectrum ATB 95% of women are afebrile by 72 hrs Acute pyelonephritis

Persistent infection Urinary tract obstruction are considered Renal sonography is recommended Obstruction Abnormal ureteral / pyelocaliceal dilatation If stone are strongly suspected despite a non diagnostic sonographic examination, a plain abdominal radiograph will identified nearly 90%/single shot IVP MRI: intrarenal or perinephric abcess or phlegmon Acute pyelonephritis

ToRCH infection

Protozoal infection Toxoplasma gondii Eating raw or undercooked meat infected with tissue cyst Contact with oocyst from cat feces in contaminated litter soil water Toxoplasmosis

Acute infection No symptoms Some cases; fatigue, fever, muscle pain, MP rash, posterior cervical lymphadenopathy Maternal infection Preterm*4 Not associated with IUGR Fetal infection higher in the 3 rd trimester Severity of fetal infection greater in early pregnancy Toxoplasmosis

Clinical manifestations Asymptomatic (70 – 90%) Signs present at birth Classic triad Chorioretinitis Intracranial calcification Hydrocephalus Hepatosplenomegaly Jaundice A nemia Toxoplasmosis

IgG confirmed before pregnancy >> no risk congenital infected fetus Investigation Maternal serology: IgG , IgM Prenatal diagnosis DNA amplification techniques (PCR) Sonographic evaluation Intracranial calcification, hydrocephaly, liver calcification, placental thickening, hyperechoic bowel Diagnosis

Spiramycin Reduce risk of congenital infection Pyrimethamine + sulfaiazine + folic acid Eradicate parasites in the placenta and fetus Management

Cooking meat to safe temperature Washing fruits and vegetables Cleaning cooking surfaces and utensils that contain raw meat, poultry, seafood or unwashed fruit and vegetables Wearing gloves when changing cat litter Avoid feeding cats raw or undercooked meat Prevention

spirochete, Treponema pallidum Infection can result in stillbirth hydrops fetalis prematurity associated long-term morbidity women with untreated early syphilis  40% of pregnancies spontaneous abortion incidence : 8.2 to 10.1 cases per 100,000 live births Transplacental transmission typically occurs during the second half of pregnancy Syphilis

Primary syphilis Chancre, painless, raised, red, firm border, smooth base Resolve 2-8 weeks 2 nd syphilis Disseminated and affect multiple organs systems Develop 4-10 weeks after chancre Diffuse MP rash, plantar and palmar targetlike lesions, patchy alopecia Clinical manifestation

Latent syphilis Not treat primary or 2 nd syphilis Reactive serology testing, resolve clinical manifestation Early latent ≤ 12 months, late latent > 12 months Late syphilis Slowly progressive disease affecting any organ system but rarely seen in reproductive aged women Clinical manifestation

Screening in the 1 st prenatal visit Symptomatic Dark field examination direct immunofluorescent antibody staining of lesion exudates Asymptomatic VDRL/RPR>>express as titers >>reflex disease activity (increase during early syphilis,>1:32 in 2 nd syphilis Following treatment of primary and 2 nd syphilis 3-6 months to confirm 4 fold drop in titers TPHA test generally remain positive throughout life Diagnosis

uncommon before 18 weeks Prenatal diagnosis is difficult Hydrops fetalis Ascites Hepatomegaly Placental thickening Prenatal diagnosis by PCR from amniotic fluid Congenital Syphilis

Clinical manifestations  Late congenital manifestations  : scarring related to early frontal bossing, short maxilla, high palatal arch Hutchinson triad Hutchinson teeth [blunted upper incisors] interstitial keratitis eighth nerve deafness saddle nose, and perioral fissures Syphilis

Category Treatment Early syphilis Benzathine penicillin G 2.4mU IM single dose –some recommend a 2 nd dose 1 week later >1 year duration Benzathine penicillin G 2.4mU IM weekly*3 doses Neurosyphilis Aqueous crystalline pen G 3-4 mU IV q 4 hrs for 10-14 days Aqueous procaine penicillin 2.4 mU IM daily+ probenecid 500 mg oral 1*4 10-14 days Treatment

Rubella (German measles)

Signs & symptoms Mild febrile illness Generalized MP rash Face to trunk and extremities Arthralgia , arthritis Head and neck lymphadenopathy Conjunctivitis Infection in the 1 st trimester>>significant risk for abortion and severe congenital malformation Viremia preceeds clinical signs about 1 wk Infectious during viremia and through 5-7 days of the rash Clinical manifestations

1 or more of the following Eye defects: cataracts and congenital glaucoma Heart disease: PDA, PAS Sensorineural deafness: most common single defect CNS defects: microcephaly , developmental delay, mental retardation, meningoencephalitis Pigmentary retinopathy Neonatal purpura (blueberry muffin) Hepatosplenomegaly and jaundice Radiolucent bone disease Congenital rubella syndrome (CRS)

Neonatal manifestations growth retardation radiolucent bone disease Hepatosplenomegaly Thrombocytopenia purpuric skin lesions “blueberry muffin” ( extramedullary hematopoiesis ) hyperbilirubinemia Rubella

Neonates with congenital rubella syndrome may shed virus for many months Extended rubella syndrome >>progressive panencephalitis and type 1 DM at 2 nd or 3 rd decade of life Congenital rubella syndromes

Symptoms and signs Serological analysis IgM antibody; 4-5 day after clinical onset IgG antibody; peak at 1-2week after rash onset Diagnosis

Confirmed maternal rubella infection in 1 st half of pregnancy Sonography Fetal growth restriction Ventriculomegaly Intracranial calcification Microcephaly Micropthalmia Cardiac malformations Meconium peritonitis Hepatosplenomegaly Rubella RNA in chorionic villi , amniotic fluid, fetal blood Confirm of fetal infection

Supportive care Droplet precaution for 7 days after onset of rash Management

MMR vaccine Live attenuated vaccine Avoid 1 month before or during pregnancy Prevention

Cytomegalovirus

Most common congenital viral infection in develop world From seropositive mothers 0.2 - 1.5% Cytomegalovirus

Primary infection Latent infection Recurrence – reactivation Clinical manifestation

Primary maternal infection during pregnancy leads to transmission 40% Intrauterine Intrapartum Breast feeding Daycare Recurrence maternal infection 0.5-1% fetal transmission Transmission methods

Primary infection Asymptomatic infection 90% 15% mononeucleosis like syndrome Fever Pharyngitis Lymphadenopathy Polyarthritis Reactivation Asymptomatic Clinical manifestation

Clinical manifestations Symptomatic infection Approximately 5 – 20% Cytomegalic inclusion disease Growth restriction Microcephaly Intracranial calcification Chorioretinitis motor disability Sensorineal deficits Jaundice Hepatosplenomegaly Hemolytic anemia Thrombocytopenic purpura Cytomegalovirus

Hearing loss Neurological deficits Chorioretinitis Psychomotor retardation Learning disabilities Late onset sequelae

CMV IgM , IgG Imaging studies Amniotic fluid studies Diagnosis

Management Symptomatic treatment Prevention No vaccine Good hygine and hand washing Management & Prevention

HSV

HSV type 1 Nongenital infections ≥50% new cases of genital herpes in adolescent and young adults HSV type 2 Genital infections Transmitted by sexual contacts HSV

1 st episode primary infection 1 st episode nonprimary infection Reactive disease Asymptomatic viral shedding Clinical manifestations

Not associated with spontaneous abortion or stillbirth Associated with preterm labor HSV and pregnancy

35% localized to eye or mouth 30% CNS disease with encephalitis 25% disseminated disease with involvement of multiple major organs Neonatal infection Kimberlin DW,clin Microbiol Rev 2004

Clinical diagnosis –insensitive and non specific Virological tests Cell culture PCR assayss Type – specific serological tests ELISA Immunoblot tests Diagnosis CDC.MMWR 2006

Management Primary infection Symptomatic recurrent infection Daily suppression Acyclovir 400 mg oral tid 7-10 days Valacyclovir 1 gm oral bid 7-10 days Acyclovir 400 mg oral tid 5 days Acyclovir 800 mg oral bid 5 days Valacyclovir 500 mg oral bid 3 days Valacyclovir 1 gm oral OD 5 days Acyclovir 400 mg oral tid Valacyclovir 500 mg oral bid From 36 week until delivery

C/S is indicated Active genital lesions Prodomal symptoms Any recurrence during pregnancy Acyclovir or valacyclovir suppression initiated at 36 weeks Peripartum shedding prophylaxis

Most newborns with perinatally acquired HSV appear normal at birth HSV infection in newborns usually develops in one of three patterns: Localized to the skin, eyes, and mouth (SEM) Localized CNS disease Disseminated disease involving multiple organs HSV

Varicella zoster virus

Primary infection Varicella or chicken pox Contagious from 1 day prior to onset of rash until the lesion crusted over Adults are more severe 5% infected pregnant develop pneumonitis (mortality 1-2%) Reactivated infection Herpes zoster or shingles No more frequent or severe in pregnant women Contagious if blisters are broken Clinical manifestations

Signs and symptoms Vesical base scraping Tzanck smear Tissue culture Direct fluorescent antibody testing VZV IgG , IgM Diagnosis
Tags